HHS Plans to Reform Organ Procurement Protocols

Follow Drugslib on

By Stephanie Brown HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 23, 2025.

via HealthDay

TUESDAY, July 22, 2025 -- The U.S. Department of Health and Human Services has announced a major initiative to reform the organ transplant system. This action follows an investigation by the Health Resources and Services Administration (HRSA) that uncovered possible troubling practices at a major organ procurement organization.

The HRSA has ordered the Organ Procurement and Transplantation Network (OPTN) to reopen a case involving potentially preventable harm to a neurologically injured patient caused by the federally funded organ procurement organization serving Kentucky, Southwest Ohio, and part of West Virginia. The administration's independent investigation uncovered negligence, contradicting the previous OPTN Board of Directors' internal review, which had claimed to find "no major concerns."

The HRSA reviewed 351 organ donation cases that were authorized but not completed and identified concerns in 103 cases. Issues included patients showing neurological signs incompatible with organ donation and patients who "may not have been deceased at the time organ procurement was initiated," raising major ethical and legal concerns. The findings further revealed poor neurological assessments, inadequate coordination with medical teams, questionable consent practices, and misclassified causes of death, especially in overdose cases, according to the HHS.

Vulnerabilities were found to be greatest in smaller and rural hospitals, revealing systemic oversight gaps. As a result, the HRSA mandated strict corrective actions for the organ procurement organization under investigation, including a full "root cause analysis" of protocol failures -- such as not observing the five-minute rule after death -- along with the development of enforceable donor eligibility criteria. The organization must also implement a formal procedure allowing any staff member to stop the donation process if patient safety is in question.

The organ procurement organization will be decertified if it "fails to comply with these corrective action requirements."

The HRSA directed the OPTN to strengthen national safeguards and monitoring to improve organ donation safety. Under this directive, all safety-related donation stoppages initiated by families, hospitals, or procurement organization staff must be reported to regulators. The OPTN must also update its policies to enhance organ procurement safety and ensure families and hospitals receive accurate, complete information about the donation process.

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-07-23 12:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords